Technological Innovation Calloway Labs leverages cutting-edge testing technologies such as high-volume screening, in-house GC/MS, and internet-based result delivery, positioning it as a leader in clinical toxicology innovation and offering opportunities for partnership in advanced diagnostic solutions.

Market Leadership As one of the fastest growing toxicology laboratories with a revenue range of 25 to 50 million dollars, Calloway presents a compelling case for expanding clinical, pharmaceutical, and healthcare collaborations to enhance drug testing and patient care services.

Regulatory Challenges Recent legal settlements related to False Claims Act and Anti-Kickback violations indicate a need for compliance consulting and risk management services, creating opportunities to support the company in strengthening regulatory adherence.

Acquisition Potential Having been acquired by Ampersand Capital Partners, Calloway is well-positioned for strategic growth initiatives, presenting opportunities to offer value-added services in scaling operations, technology upgrades, or compliance improvements to support its expansion.

Industry Collaboration Calloway collaborates closely with medical and treatment professionals to educate on regulatory developments, providing avenues to develop training, educational tools, and compliance solutions tailored to medical and healthcare customers.